Exco InTouch will address mobile ePRO issues, the changing role of patients and best practices to meet pharma’s demand to bring clinical studies into the 21st Century at the DIA Annual Meeting
09 June 2015: Exco InTouch, the leading provider of patient engagement and data capture solutions for clinical research and healthcare providers, joins DIA 2015 to address key challenges facing modern day clinical trials and showcase the solutions available to achieve the scale of efficiencies demanded by the pharmaceuticals industry. Advancing the use of patient engagement and mobile ePRO (electronic Patient Reported Outcomes) solutions are critical to achieving this goal.
DIA 2015 will focus on the healthcare industry’s shift towards a more patient-centric phase in which keeping patients fully engaged throughout their participation in clinical studies is critical to efficient and accurate PRO data capture. Furthermore, maximizing the use of mobile and digital tools, beyond their application in supporting patients in clinical trials and into the sphere of disease management in people’s everyday lives, is seen as a trend that has major scope for significant expansion.
eCOA (electronic Clinical Outcome Assessments) solutions are also set to take center stage. With mobile and digital technologies now a widely-used and a familiar factor in everyday lives, their ready availability makes them a perfect asset for use throughout the healthcare continuum, both in clinical research and healthcare industries to address today’s complex health challenges.
Exco InTouch is continuing to lead the ePRO mobile and digital technology market. The company recently released its co-authored White Paper that focuses on the benefits and key considerations behind implementing a mobile strategy for patient data capture in clinical research. Moreover, it analyzes how the use of mobile eCOA solutions overcomes practical challenges of capturing PRO measures through better quality, reliability, integrity and traceability of the collected data.
Tim Davis, CEO and Founder of Exco InTouch commented: “Exco is looking forward to showcasing our strengths as the industry leaders in implementing mobile strategies for patient data capture in clinical research. The event provides us with a highly useful platform to share our insights into how best to meet the current, critical clinical trials challenges, whilst further strengthening our leadership position in the application of mobile in eCOA and patient engagement solutions.”
Chris Watson, Product Manager, who will present with the ePRO Consortium, commented: “The pharma industry is looking for more efficient means to capture patient data and ensure its reliability quality, traceability and integrity. The use of mobile technology in clinical research is on the rise and has the potential to address the challenges affecting paper and traditional ePRO methods.”
He added: “We are pleased to be playing our role in the strong focus at DIA 2015 on the changing role of patients. Indeed, this has important implications for advanced mobile and digital technology. Modules that provide help in managing health are set to become important mainstays in the very near future. and can be combined with workflows, rules and content to build individual and highly innovative patient engagement solutions in either clinical research or the real world with learnings being fed back into future development efforts.”
Exco InTouch we will be demonstrating its services at the booth number 2212.
-ENDS-
About Exco InTouch
Exco InTouch is the leading provider of digital patient engagement and data capture solutions for clinical research and healthcare providers. Using a combination of software and services, Exco InTouch solutions provide simple, secure channels of communication; facilitating the collection of quality data and improving outcomes for sponsors, clinical research organizations, sites and patients.
Working across clinical and late phase trials and mHealth programs, Exco InTouch’s device inclusive approach enables involvement which integrates into daily life - resulting in motivated and compliant patients, reducing costs associated with withdrawals from trials and improving overall program results.
Since 2004, Exco InTouch has engaged with over 1 million patients across 97 countries, over 26,000 hospitals and clinics, in 70 languages. 16 of the top 20 pharmaceutical companies have deployed our trusted applications in the knowledge that data is secure and protected, in line with global regulatory and data protection requirements.
For media enquiries, please contact Tristan Jervis or Alex Heeley on +44 (0) 207 203 6740 or e-mail: t.jervis@defacto.com
Help employers find you! Check out all the jobs and post your resume.
